Newsletter Subject

New Issue: What Was It Like to Be a Dinosaur?

From

sciam.com

Email Address

news@scientificamerican.com

Sent On

Thu, Aug 22, 2024 08:01 PM

Email Preheader Text

Read our September Issue on dinosaurs, dark matter, a new painkiller, and more! New Issue: September

Read our September Issue on dinosaurs, dark matter, a new painkiller, and more! [SciAm Logo]( New Issue: September 2024 [What Was It Like to Be a Dinosaur? ]( [Read the Issue]( Dear Friend of Scientific American, We have some hopeful news in our [September issue]( about [a new type of painkiller](. One in five adults in the U.S. live with chronic pain, and almost everyone suffers from occasional pain. Over-the-counter drugs are often not enough, and opioids put people at risk of addiction and overdose. The new class of drug, the first one of which could be approved this year, works on the peripheral nervous system to stop pain signals from reaching the brain. We’re very cautious about overstating medical advances, but everyone our writer spoke with is optimistic about this new approach to pain management. Our cover story in this issue asks [What Was It Like to Be a Dinosaur?]( answers that question with some surprisingly sophisticated insights into their behaviors and sensations. Our expert authors, an evolutionary biologist and paleontologist, explain what they’ve learned from merging neuroscience studies of living animals’ brains with lots of analyses of dinosaur skulls. The illustration, by a [paleoartist who also creates museum displays]( made some of us in the office go “grawr!” [Capturing carbon dioxide in the air]( and storing it someplace harmless could potentially help slow global warming. Governments and private industry are investing billions, and the sector is suddenly growing very quickly. We explain how it works, why fossil fuel companies are so interested, and what technologies are being developed (the graphics help a lot). This is the first in a series of three stories about different types of carbon capture, with the next one coming in a few months. The physicists seeking an explanation for [dark matter are getting concerned](. They thought they would have found it by now. This mysterious stuff exerts gravitational pull on everything we observe, but is not itself observable. When it was first detected, physicists came up with a lot of possible explanations and started testing them, with no success. Now some experts say we may never be able to figure out its true nature. One reason we have new pain medications (and vaccines, cancer drugs, antivirals and more) is that lab rats and other animal models allow researchers to test new compounds. But biomedical research has advanced so much that much of it is [moving beyond guinea pigs]( – new organoids, organs on a chip, machine learning and other technologies are replacing lab animals. Lab animals were always imperfect proxies for the human body, giving false positives (drugs that work in them don’t work in humans) and false negatives (drugs that would work in humans never get developed because they fail in animal models). It’s exciting to see these new techniques start to change how science is done. Thanks so much for your support of Scientific American. Enjoy our [September issue]( and more with our special offer: [90 days of unlimited digital access for $1!]( Best wishes, Laura Helmuth Editor in Chief Issue Highlights [Dinosaur]( [What Was It Like to Be a Dinosaur?]( New fossils and analytical tools provide unprecedented insights into dinosaur sensory perception. [Mystical desk]( [What If We Never Find Dark Matter?]( Dark matter has turned out to be more elusive than physicists had hoped. [Pulverized lime on plastic trays]( [Can Pulling Carbon from Thin Air Slow Climate Change?]( Tech firms, oil companies and the U.S. government are investing billions of dollars in carbon capture technology to suck greenhouse gases out of the atmosphere. Can it save the warming world? [White rat]( [The End of the Lab Rat?]( Replacing research animals with tools that better mimic human biology could improve medicine. [Thermal art of person]( [New Painkiller Could Bring Relief to Millions—Without Addiction Risk]( The medication initially known as VX-548 blocks sodium channels in nerves, blocking pain signals before they reach the brain. [Shapes of space and time]( [Can Space and Time Exist as Two Shapes at Once? Mind-Bending Experiments Aim to Find Out]( Proposed experiments will search for signs that spacetime is quantum and can exist in a superposition of multiple shapes at once. [Read the Issue]( [Want more science? Get 90 days of digital access for $1.]( To view this email as a web page, [go here](. You received this email because you opted-in to receive email from Scientific American or you have registered for an account with Scientific American. To ensure delivery please add specialoffers@scientificamerican.com to your address book. [Unsubscribe]( [Email Preferences]( [Privacy Policy]( [Contact Us](

EDM Keywords (0)

Marketing emails from sciam.com

View More
Sent On

08/11/2024

Sent On

21/10/2024

Sent On

17/10/2024

Sent On

16/10/2024

Sent On

14/10/2024

Sent On

10/10/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.